SCHEMBL13625815

SCHEMBL13625815

CCCc1cc(F)ccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.55
LMNA P02545 1/20 0.51
MAPT P10636 1/20 0.51
XBP1 P17861 1/20 0.51
HIF1A Q16665 1/20 0.51
ALOX5 P09917 2/20 0.50
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
F2RL1 P55085 3/20 0.43
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
PRKCI P41743 1/20 0.42
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
TYR P14679 1/20 0.41
GABRA1 P14867 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12520531 0.88 TYR (0.56) HMGCRLMNAMAPTXBP1HIF1A
SCHEMBL1270868 0.86 ALOX5 (0.56) HMGCRLMNAMAPTALOX5TYR
SCHEMBL13563249 0.85 TYR (0.52) HMGCRLMNAMAPTXBP1HIF1A
SCHEMBL15177138 0.85 ALOX5 (0.59) LMNAMAPTALOX5TYR
SCHEMBL5208612 0.85 ALOX5 (0.57) HMGCRLMNAMAPTXBP1HIF1A
SCHEMBL364672 0.83 ESR1 (0.53) LMNAMAPTESR1ESR2CA3
SCHEMBL2410166 0.81 PPARG (0.48) HMGCRLMNAMAPTXBP1HIF1A
Formaldehyde SCHEMBL27493223 0.80 MAPT (0.49) HMGCRLMNAMAPTXBP1HIF1A
SCHEMBL21455683 0.80 HMGCR (0.40) HMGCRLMNAMAPTXBP1HIF1A
SCHEMBL24648555 0.79 LMNA (0.52) LMNAMAPTXBP1HIF1AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3974419-A2 NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2022-03-30 EP disclosed
US-8486943-B2 Tetrahydrocyclopenta[b]indole androgen receptor modulators ELI LILLY AND COMPANY (US) 2013-07-16 US disclosed
WO-2009140448-A1 TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2009-11-19 WO disclosed